The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baetu, T. M.
Right arrow Articles by Hiscott, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baetu, T. M.
Right arrow Articles by Hiscott, J.
The Journal of Immunology, 2001, 167: 3164-3173.
Copyright © 2001 by The American Association of Immunologists

Disruption of NF-{kappa}B Signaling Reveals a Novel Role for NF-{kappa}B in the Regulation of TNF-Related Apoptosis-Inducing Ligand Expression1

Tudor M. Baetu*,{dagger},{ddagger}, Hakju Kwon*,{dagger}, Sonia Sharma*,{dagger},{ddagger}, Nathalie Grandvaux*,{dagger} and John Hiscott2,*,{dagger},{ddagger},§

* Terry Fox Molecular Oncology Group, {dagger} Lady Davis Institute for Medical Research, and Departments of {ddagger} Microbiology and Immunology and § Medicine and Oncology, McGill University, Montreal, Canada

The NF-{kappa}B family of transcription factors functions broadly in the host control of immunoregulatory gene expression, inflammation, and apoptosis. Using Jurkat T cells engineered to inducibly express a transdominant repressor of I{kappa}B{alpha}, we examined the role of NF-{kappa}B in the regulation of cytokine and apoptotic gene expression. In this T cell model, as well as in primary T lymphocytes, expression of TNF-related apoptosis-inducing ligand (TRAIL) apoptotic signaling protein was dramatically down-regulated by inhibition of NF-{kappa}B binding activity. TRAIL acts through membrane death receptors to induce apoptosis of activated T lymphocytes and can be up-regulated by a variety of physiological and pharmacological inducers. However, regulation of TRAIL gene expression has not been defined. Treatment with TCR mimetics (PMA/ionomycin, PHA, and anti-CD3/CD28 Abs) resulted in a rapid increase in the expression of TRAIL mRNA and cell surface TRAIL protein. Induction of the transdominant repressor of I{kappa}B{alpha} dramatically down-regulated surface expression of TRAIL, indicating an essential role for NF-{kappa}B in the regulation of TRAIL. The induced expression of TRAIL was linked to a c-Rel binding site in the proximal TRAIL promoter at position -256 to -265; mutation of this site or an adjacent {kappa}B site resulted in a complete loss of the inducibility of the TRAIL promoter. The regulation of TRAIL expression by NF-{kappa}B may represent a general mechanism that contributes to the control of TRAIL-mediated apoptosis in T lymphocytes.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Ban, J. Zhang, L. Wang, W. Kuhtreiber, D. Burger, and D. L. Faustman
Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism
PNAS, September 9, 2008; 105(36): 13644 - 13649.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Xu, J.-Y. Zhou, W.-Z. Wei, S. Philipsen, and G. S. Wu
Sp1-Mediated TRAIL Induction in Chemosensitization
Cancer Res., August 15, 2008; 68(16): 6718 - 6726.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Fionda, F. Nappi, M. Piccoli, L. Frati, A. Santoni, and M. Cippitelli
Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 in T Lymphocytes
Mol. Pharmacol., November 1, 2007; 72(5): 1246 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Lin, W. Wei, J. Zhang, S. Liu, Y. Liu, and D. Zheng
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity
Mol. Cancer Ther., October 1, 2007; 6(10): 2618 - 2625.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. N. Ivanov, H. Zhou, and T. K. Hei
Sequential Treatment by Ionizing Radiation and Sodium Arsenite Dramatically Accelerates TRAIL-Mediated Apoptosis of Human Melanoma Cells
Cancer Res., June 1, 2007; 67(11): 5397 - 5407.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Y. Kimura, C. Iwamura, A. Suzuki, T. Miki, A. Hasegawa, K. Sugaya, M. Yamashita, S. Ishii, and T. Nakayama
Schnurri-2 Controls Memory Th1 and Th2 Cell Numbers In Vivo
J. Immunol., April 15, 2007; 178(8): 4926 - 4936.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. T. Taylor and W. A. Bresnahan
Human Cytomegalovirus IE86 Attenuates Virus- and Tumor Necrosis Factor Alpha-Induced NF{kappa}B-Dependent Gene Expression.
J. Virol., November 1, 2006; 80(21): 10763 - 10771.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Xu, J.-Y. Zhou, and G. S. Wu
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Is Required for Tumor Necrosis Factor {alpha}-Mediated Sensitization of Human Breast Cancer Cells to Chemotherapy.
Cancer Res., October 15, 2006; 66(20): 10092 - 10099.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
F. O. Baxter, P. J. Came, K. Abell, B. Kedjouar, M. Huth, K. Rajewsky, M. Pasparakis, and C. J. Watson
IKK{beta}/2 induces TWEAK and apoptosis in mammary epithelial cells
Development, September 1, 2006; 133(17): 3485 - 3494.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Huang, E. Bi, Y. Hu, W. Deng, Z. Tian, C. Dong, Y. Hu, and B. Sun
A Novel NF-{kappa}B Binding Site Controls Human Granzyme B Gene Transcription
J. Immunol., April 1, 2006; 176(7): 4173 - 4181.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. R. Kirshner, A. Y. Karpova, M. Kops, and P. M. Howley
Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target
J. Virol., July 15, 2005; 79(14): 9320 - 9324.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. Matsuda, A. Almasan, M. Tomita, K. Tamaki, M. Saito, M. Tadano, H. Yagita, T. Ohta, and N. Mori
Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand
J. Gen. Virol., April 1, 2005; 86(4): 1055 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Matsuda, A. Almasan, M. Tomita, J.-n. Uchihara, M. Masuda, K. Ohshiro, N. Takasu, H. Yagita, T. Ohta, and N. Mori
Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines
J. Virol., February 1, 2005; 79(3): 1367 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. J. Wurzer, C. Ehrhardt, S. Pleschka, F. Berberich-Siebelt, T. Wolff, H. Walczak, O. Planz, and S. Ludwig
NF-{kappa}B-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation
J. Biol. Chem., July 23, 2004; 279(30): 30931 - 30937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. N. Ivanov and T. K. Hei
Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor {alpha}-mediated Pathway
J. Biol. Chem., May 21, 2004; 279(21): 22747 - 22758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. M. Droin, M. J. Pinkoski, E. Dejardin, and D. R. Green
Egr Family Members Regulate Nonlymphoid Expression of Fas Ligand, TRAIL, and Tumor Necrosis Factor during Immune Responses
Mol. Cell. Biol., November 1, 2003; 23(21): 7638 - 7647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Chawla-Sarkar, J. A. Bauer, J. A. Lupica, B. H. Morrison, Z. Tang, R. K. Oates, A. Almasan, J. A. DiDonato, E. C. Borden, and D. J. Lindner
Suppression of NF-{kappa}B Survival Signaling by Nitrosylcobalamin Sensitizes Neoplasms to the Anti-tumor Effects of Apo2L/TRAIL
J. Biol. Chem., October 10, 2003; 278(41): 39461 - 39469.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Mahr, J. M. Boss, and L. R. Gooding
The Adenovirus E3 Promoter Is Sensitive to Activation Signals in Human T Cells
J. Virol., December 20, 2002; 77(2): 1112 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Baumann, F. Bohnenstengel, D. Siegmund, H. Wajant, C. Weber, I. Herr, K.-M. Debatin, P. Proksch, and T. Wirth
Rocaglamide Derivatives Are Potent Inhibitors of NF-kappa B Activation in T-cells
J. Biol. Chem., November 15, 2002; 277(47): 44791 - 44800.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Ren, A. Schmalstieg, N. S. C. van Oers, and R. B. Gaynor
I-{kappa}B Kinases {alpha} and {beta} Have Distinct Roles in Regulating Murine T Cell Function
J. Immunol., April 15, 2002; 168(8): 3721 - 3731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.